Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Juvista Safety and Anti-scarring in Females
NCT00984581Phase 2Completed
- Sponsor
- Renovo
- Start
- Apr 2003
- Primary completion
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cicatrix comparing Intradermal avotermin with Placebo (2 arms). Primary endpoint: Safety and tolerability data for intradermal injection of Juvista at Month 6. Started Apr 2003; status: completed.
02
Drugs
avotermin
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT00984581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984581.